|
Market Cap (19-May) $8,702,824,448 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $14.42 |
P/E 59.52 |
EPS 0.15 |
TLX released this announcement to the ASX on 31 March 2022, 8:54. The announcement is not marked as price sensitive, and is 3 page(s) in length and 233.92kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 2.574% short sold according to ASIC data. It was ranked the 81st most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Change of Composition of the Telix Board of Directors | 31 March 2022, 8:54 |
| FDA Orphan Drug Designation for Bone Marrow Conditioning | 29 March 2022, 11:05 |
| Telix and Xiel Sign U.K. and Ireland Distribution Agreement | 29 March 2022, 8:53 |
| Cleansing Notice under S708A(5)(e) Corporations Act | 24 March 2022, 8:19 |
You must be logged in to post a reply.
Telix Pharmaceuticals 